Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
2023; Adis, Springer Healthcare; Volume: 18; Issue: 4 Linguagem: Inglês
10.1007/s11523-023-00978-2
ISSN1776-260X
AutoresMatteo Santoni, Francesco Massari, Zin Myint, Roberto Iacovelli, Martin Pichler, Umberto Basso, Jindřich Kopecký, Jakub Kucharz, Sebastiano Buti, Mimma Rizzo, Luca Galli, Thomas Büttner, Ugo De Giorgi, Ravindran Kanesvaran, Ondřej Fiala, Enrique Grande, Paolo Andrea Zucali, Giuseppe Fornarini, María T. Bourlon, Sarah Scagliarini, Javier Molina‐Cerrillo, Gaetano Aurilio, Marc Matrana, Renate Pichler, Carlo Cattrini, Tomáš Büchler, Emmanuel Seront, Fabio Calabrò, Álvaro Pinto, Rossana Berardi, Anca Zgură, Giulia Mammone, Jawaher Ansari, Francesco Atzori, Rita Chiari, Aristotelis Bamias, Orazio Caffo, Giuseppe Procopio, Maria Bassanelli, Sara Merler, Carlo Messina, Zsófia Kürönya, Alessandra Mosca, Dipen Bhuva, Nuno Vau, Lorena Incorvaia, Sara Elena Rebuzzi, Giandomenico Roviello, Ignacio Ortego Zabalza, Alessandro Rizzo, Veronica Mollica, Giulia Sorgentoni, Fernando Sabino Marques Monteiro, Rodolfo Montironi, Nicola Battelli, Camillo Porta,
Tópico(s)Cancer Immunotherapy and Biomarkers
Referência(s)